Early Adalimumab Leads to Better Outcomes for Psoriatic Arthritis Patients

Researchers found that, in this real-world clinical setting, patients with PsA who had a shorter disease duration achieved better results after treatment with adalimumab than did patients with a longer disease duration. This finding adds support to the idea that shorter symptom duration and earlier treatment with adalimumab could lead to a more favorable outcome in patients with PsA. Researchers did note, however, that further studies are needed to confirm these results.

Source: Early Adalimumab Leads to Better Outcomes for Patients With Psoriatic Arthritis

thumbnail courtesy of centerforbiosimilars.com

You can find more psoriasis and psoriatic arthritis news on our news page.

Additional reading: Lifestyle Changes to Manage Psoriasis – These Improvements Work!

The blog post Early Adalimumab Leads to Better Outcomes for Psoriatic Arthritis Patients is courtesy of: Mike Walker

Comments

Popular posts from this blog

Gold Bond Psoriasis Relief Cream Review

MG217 Psoriasis Cream Review

How Does MetaDerm Psoriasis Cream Compare to Competitors?